STM publisher Elsevier has announced the first issue of its new open access journal - Contemporary Clinical Trials Communications. The issue features a new method to make cancer clinical trials more effective, a better way of determining whether a trial was successful and a dashboard that helps patients enroll in trials. The journal is a spin-off of the well-established title Contemporary Clinical Trials.
There are many ways to carry out a clinical trial. Researchers need to think about the number of patients to enroll, the type of treatments to give and their frequency, among many other factors. Contemporary Clinical Trials Communications publishes methodology and statistics that answer these questions, helping researchers build on each other's work and design better trials.
The journal also aims to tackle the problem of publication bias towards positive results by making all trial data open access. The first issue is now available on ScienceDirect.
There are two main approaches to clinical trials: randomized and non-randomized. In randomized trials, the participants do not know whether they are receiving the treatment or a placebo. In non-randomized trials, the participants are often all given the treatment. While several clinical trials journals only publish randomized trials, Contemporary Clinical Trials Communications will publish both.
Contemporary Clinical Trials Communications is now open for submissions.
Brought to you by Scope e-Knowledge Center, a world-leading provider of abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).
